A number of other brokerages have also recently issued reports on HUM. UBS Group raised Humana from a “neutral” rating to a “buy” rating and raised their price objective for the company from $486.00 to $520.00 in a research note on Wednesday, April 13th. Truist Financial boosted their price objective on Humana from $460.00 to $490.00 in a research report on Thursday, April 7th. Deutsche Bank Aktiengesellschaft increased their price objective on Humana from $418.00 to $435.00 in a research note on Thursday, February 3rd. Sanford C. Bernstein lowered their price target on shares of Humana from $470.00 to $431.00 in a report on Tuesday, January 11th. Finally, Wells Fargo & Company cut their price target on shares of Humana from $529.00 to $452.00 in a report on Friday, January 7th. Seven research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Humana has a consensus rating of “Buy” and an average target price of $484.55.
Shares of HUM stock opened at $458.69 on Wednesday. The business’s fifty day moving average is $436.89 and its 200 day moving average is $432.84. Humana has a 52-week low of $351.20 and a 52-week high of $475.44. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.62 and a current ratio of 1.62. The company has a market capitalization of $58.14 billion, a PE ratio of 20.23, a price-to-earnings-growth ratio of 1.40 and a beta of 0.94.
Several institutional investors and hedge funds have recently added to or reduced their stakes in HUM. Bell Investment Advisors Inc purchased a new position in shares of Humana during the third quarter valued at approximately $26,000. Spire Wealth Management bought a new stake in Humana during the fourth quarter valued at approximately $30,000. BerganKDV Wealth Management LLC grew its position in Humana by 885.7% during the fourth quarter. BerganKDV Wealth Management LLC now owns 69 shares of the insurance provider’s stock valued at $32,000 after buying an additional 62 shares during the period. Selective Wealth Management Inc. bought a new stake in Humana during the fourth quarter valued at approximately $35,000. Finally, Cordasco Financial Network grew its position in Humana by 32.0% during the third quarter. Cordasco Financial Network now owns 99 shares of the insurance provider’s stock valued at $39,000 after buying an additional 24 shares during the period. 92.96% of the stock is owned by hedge funds and other institutional investors.
Humana Company Profile (Get Rating)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Get a free copy of the StockNews.com research report on Humana (HUM)
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
- J.B. Hunt Transportation Services Fires On All Cylinders
- 3 No-Brainer Stocks to Buy with $1000
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.